A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.
Effectiveness of Pulmonary Rehabilitation in Interstitial Lung Disease, Including Coronavirus Diseases: A Systematic Review and Meta-analysis
Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP
Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases
Prospective options of algae-derived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases